» Articles » PMID: 38558894

Autoimmune Diseases and Myelodysplastic Syndromes

Overview
Journal Reumatologia
Publisher Termedia
Specialty Rheumatology
Date 2024 Apr 1
PMID 38558894
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune diseases (ADs) and myelodysplastic syndrome (MDS) may be associated in approximately 10-20% of cases. Although this association has been well recognized, it is not always easily diagnosed. The exact physiopathological mechanism involved has yet to be determined but seems to be multifactorial. The therapeutic decision is not well codified and often represents a challenge. But overall, glucocorticosteroids have generally proven to be effective at the expense of a high incidence of dependence and relapse. This review aims to summarize and analyze all aspects of this association to provide an overview for practitioners and clinicians. A scientific search in databases (PubMed, Scopus, Web of Science, Google Scholar) was conducted using a combination of key words such as autoimmune diseases, myelodysplastic syndromes, and association. Articles from 1992 to 2022 were considered and relevant data were collected and summarized to provide a coherent detailed overview of the coexistence of ADs and MDS.

References
1.
Paira S, Graf C, Roverano S, Rossini J . Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases. Clin Rheumatol. 2002; 21(2):146-9. DOI: 10.1007/pl00011218. View

2.
Fozza C, Murtas A, Caocci G, La Nasa G . Autoimmune disorders associated with myelodysplastic syndromes: clinical, prognostic and therapeutic implications. Leuk Res. 2022; 117:106856. DOI: 10.1016/j.leukres.2022.106856. View

3.
Koutroubakis I, Manousos O, Meuwissen S, Pena A . Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology. 1996; 43(8):381-93. View

4.
Mekinian A, Braun T, Decaux O, Falgarone G, Toussirot E, Raffray L . Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases. Medicine (Baltimore). 2014; 93(1):1-10. PMC: 4616329. DOI: 10.1097/MD.0000000000000011. View

5.
Toyonaga T, Nakase H, Matsuura M, Minami N, Yamada S, Honzawa Y . Refractoriness of intestinal Behçet's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature. Digestion. 2013; 88(4):217-21. DOI: 10.1159/000355341. View